SONOSCANNER, French manufacturer of ultrasound devices, is announcing FDA (Food and Drug Administration) approval of the ultra-portable T-Lite Ultrasound for the American market, confirming and reinforcing the Company’s international growth strategy.
This approval, obtained on October 15th, 2020, places SONOSCANNER among the few French-technology companies to have satisfied the rigorous and demanding requirements of the American Public Health Authorities. It is also an additional confirmation of the quality of the Sonoscanner ultrasound devices, and represents a key milestone in the development of the SONOSCANNER international growth strategies, by authorizing the commercialization of the T-Lite Ultrasound in the American market.
The ultra-portable T-Lite model is the only ultrasound worldwide that combines an ultra-portability in tablet format, with an exceptional imaging quality, all the Doppler frequencies and a feature-rich functionality (private Cloud functions, automated reports). The T-Lite Ultrasound is bound for strong growth in the American market.
More information : https://www.sonoscanner.com/en/fda-aproval-t-lite/